| |
|
|
|
Novabay Pharmaceuticals  
|
|
1.32 -0.08 (-0.06%) |
07-14 16:00 |
|
Open: |
1.37 |
Pre close: |
1.4 |
Target:
|
1.76 
|
|
High: |
1.38 |
Low: |
1.22 |
Resistance:
|
1.51
1.94
|
|
Volume: |
6,412,976 |
Market Cap: |
44M |
Support:
|
0.81
0.67
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.23
 |
MACD |
MACD(12,26):
|
0.09 |
|
MA(20): |
1.10 |
Signal(12,26,9): |
0.07 |
|
MA(100): |
0.86 |
Stochastic Oscillator |
%K(14,3):
|
46.94 |
|
MA(250): |
0.74 |
%D(3): |
55.22 |
|
Average Volume(K) |
3-Month: |
602141
|
52-Week |
High:
|
1.94 |
|
10-Days: |
1284962 |
Low: |
0.24 |
|
RSI |
RSI(14):
|
64.45 |
Change(%): |
4.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.323 |
Return on Equity (ttm) |
-1807.9 |
Shares Out. (M) |
33.38 |
|
EPS Est. Current Year |
-0.470 |
Return on Assets (ttm) |
-43.0 |
Shares Float (M) |
16.83 |
|
EPS Est. Next Year |
-0.090 |
PEG Ratio |
0.00 |
% Held by Insiders |
41.27 |
|
EPS Est. Next Quarter |
-0.030 |
Qtrly Rev. Growth |
30.5 |
% Held by Institutions |
6.53 |
|
Forward EPS |
-0.480 |
Gross Profit (p.s.) |
0.146 |
Shares Short (K) |
249 |
|
Book Value (p.s.) |
-0.010 |
EBITDA (p.s.) |
-0.196 |
P/E |
-4.09 |
|
Sales Per Share |
0.211 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-132.00 |
|
Profit Margin |
-100.14 |
Operating Cash Flow
(M) |
-5.57 |
P/S |
6.26 |
|
Operating Margin |
-93.82 |
Levered Free Cash Flow
(M) |
-2.10 |
P/CF |
-7.91 |
|
|
|
|
|
|
